
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Mobile-health Network Solutions Class A Ordinary Shares (MNDR)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: MNDR (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $8
1 Year Target Price $8
1 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.98M USD | Price to earnings Ratio - | 1Y Target Price 8 |
Price to earnings Ratio - | 1Y Target Price 8 | ||
Volume (30-day avg) 1 | Beta - | 52 Weeks Range 3.05 - 40.00 | Updated Date 10/17/2025 |
52 Weeks Range 3.05 - 40.00 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -36.49 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -136.17% | Operating Margin (TTM) -40.92% |
Management Effectiveness
Return on Assets (TTM) -245.45% | Return on Equity (TTM) -1216.34% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 6956388 | Price to Sales(TTM) 0.69 |
Enterprise Value 6956388 | Price to Sales(TTM) 0.69 | ||
Enterprise Value to Revenue 0.6 | Enterprise Value to EBITDA -291.96 | Shares Outstanding 936956 | Shares Floating 476563 |
Shares Outstanding 936956 | Shares Floating 476563 | ||
Percent Insiders 16.27 | Percent Institutions 2.25 |
Upturn AI SWOT
Mobile-health Network Solutions Class A Ordinary Shares

Company Overview
History and Background
Mobile-health Network Solutions is a China-based digital healthcare platform. Founded in 2011, it initially focused on providing pharmaceutical supply chain solutions and has expanded into online consultation, chronic disease management, and other health services. The company has evolved to connect patients, doctors, pharmacies, and pharmaceutical companies.
Core Business Areas
- Online Retail Pharmacy: Operates online pharmacies, offering prescription and over-the-counter medications, as well as health products.
- Online Medical Consultation: Provides online consultation services with licensed doctors, enabling patients to seek medical advice remotely.
- Chronic Disease Management: Offers programs for managing chronic conditions such as diabetes and hypertension, including medication reminders and health tracking.
- Pharmaceutical Supply Chain Solutions: Provides solutions for pharmacies and pharmaceutical companies to connect them with patients and doctors.
Leadership and Structure
The company's leadership includes executive officers focusing on technology, finance, and operations. The organizational structure reflects a matrix organization, with teams dedicated to specific service areas and functional roles.
Top Products and Market Share
Key Offerings
- Online Pharmacy Services: Provides a platform for patients to purchase medications online. It is estimated that the China's online pharmacy market is dominated by Alibaba Health and JD Health, with Mobile-Health having much smaller portion. Competitors include Alibaba Health, JD Health, and Dingdong Maicai.
- Online Doctor Consultation: Offers remote consultations with doctors via its platform. It is also estimated that Alibaba Health and JD Health dominate in this segment as well. Competitors include Alibaba Health, JD Health and WeDoctor.
- Chronic Disease Management Programs: Helps patients manage chronic conditions through personalized programs and health tracking tools. Major competitors are similar to Online Doctor Consultations and Online Pharmacy Service.
Market Dynamics
Industry Overview
The digital healthcare industry is experiencing rapid growth due to increased internet penetration, government support, and rising demand for convenient healthcare services. The market is becoming increasingly competitive with both established players and startups entering the field.
Positioning
Mobile-health Network Solutions seeks to be a comprehensive digital healthcare platform. Its competitive advantage lies in its established pharmacy network and integrated service offerings.
Total Addressable Market (TAM)
The total addressable market for digital healthcare in China is substantial. The projected TAM is estimated to be around $400 Billion by 2030. Mobile-health Network Solutions is positioning itself to capture a share of this market by expanding its service offerings and strengthening its pharmacy network.
Upturn SWOT Analysis
Strengths
- Established Pharmacy Network
- Integrated Service Offerings (online pharmacy, consultation, chronic disease management)
- Strong Brand Recognition in certain regions of China
- Growing user base
Weaknesses
- High dependence on regulatory approvals in China
- Intense competition from larger players
- Limited international presence
- Profitability concerns
Opportunities
- Expanding service offerings into new areas (e.g., elderly care)
- Leveraging partnerships with hospitals and pharmaceutical companies
- Growing demand for digital healthcare services in China
- Increasing internet penetration in rural areas
Threats
- Changing government regulations
- Intensifying competition from Alibaba Health, JD Health, and others
- Data security and privacy concerns
- Economic slowdown in China
Competitors and Market Share
Key Competitors
- ALBABA (9988.HK)
- JD Health (6618.HK)
Competitive Landscape
Mobile-health Network Solutions faces intense competition from Alibaba Health and JD Health, which have larger market shares and more resources. However, Mobile-health Network Solutions differentiates itself through its pharmacy network and integrated service offerings.
Growth Trajectory and Initiatives
Historical Growth: The company has experienced strong historical growth driven by the expansion of its service offerings and increasing user adoption of digital healthcare solutions.
Future Projections: Analysts project continued growth for Mobile-health Network Solutions, with revenue expected to increase by 15-20% annually over the next few years. Growth is expected to be driven by the increasing demand for online pharmacy and online consulation.
Recent Initiatives: Recent initiatives include expanding its chronic disease management programs, strengthening its pharmacy network, and investing in new technologies such as AI and blockchain.
Summary
Mobile-health Network Solutions is positioned in the growing digital healthcare market in China with an established pharmacy network and integrated service offerings. It faces intense competition from larger players, but continues to innovate with new technologies and strategic partnerships. Its revenue has shown consistant growth. Regulatory changes and data security concerns pose potential threats to the company's growth trajectory.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, industry reports, market analysis reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be made based on your own research and due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mobile-health Network Solutions Class A Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-04-10 | Co-CEO & Director Dr. Tung Yeng Siaw | ||
Sector Healthcare | Industry Health Information Services | Full time employees 73 | Website https://manadr.com |
Full time employees 73 | Website https://manadr.com |
Mobile-health Network Solutions, an investment holding company, provides telehealth solutions primarily in Singapore. The company operates in two segments: Telemedicine and Other Services and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The company also provides a suite of medical-related and other services, including teleconsultations and health check-up services, vaccinations, skin and aesthetics services, and other services. In addition, it offers healthcare and wellness products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical services. The company was founded in 2009 and is headquartered in Singapore.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.